Loading...
NPI 1306878988 · Glasgow, KY · Community/Retail Pharmacy
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Ely Drugs Inc is a community/retail pharmacy provider located in Glasgow, Kentucky. This profile covers 10 Medicare and 44 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Ely Drugs Inc |
| Address | 415 Happy Valley Rd |
| City | Glasgow |
| State | KY |
| ZIP | 42141 |
| Taxonomy | Community/Retail Pharmacy |
| NPI Enumerated | July 6, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $729.2K |
| Medicare | $74.8K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
10 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 2,740 | $10 | $32.8K |
| 91322 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL. | 100 | $140 | $14.4K |
| 90694 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is an inactivated, adjuvanted, preservative–free vaccine given as a 0.5 mL… | 180 | $80 | $13.8K |
| G0008 | Administration of influenza virus vaccine | 210 | $30 | $5.9K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 110 | $40 | $4.3K |
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 10 | $130 | $1.4K |
| M0201 | Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patient's home; reported only once per individual home per date of service when such vaccine administration(s)… | 30 | $30 | $850 |
| 90674 | This code represents a flu vaccine product that protects against four strains of influenza. It is derived from cell cultures, contains no preservatives or antibiotics, and is administered as a 0.5 mL… | 20 | $30 | $760 |
| 0124A | N/A | 20 | $40 | $650 |
| 0134A | N/A | 20 | $40 | $610 |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 10 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
44 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| E1390 | Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate | 3,920 | $30 | $133.1K |
| E0570 | Nebulizer, with compressor | 2,360 | $40 | $103.9K |
| A7031 | Face mask interface, replacement for full face mask, each | 3,910 | $20 | $82.1K |
| E0601 | Continuous positive airway pressure (CPAP) device | 2,500 | $30 | $72.4K |
| A7030 | Full face mask used with positive airway pressure device, each | 960 | $50 | $43K |
| A4604 | Tubing with integrated heating element for use with positive airway pressure device | 1,650 | $30 | $41.4K |
| E0470 | Respiratory assist device, bi-level pressure capability, without backup rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive… | 460 | $60 | $28.2K |
| E0562 | Humidifier, heated, used with positive airway pressure device | 1,090 | $20 | $26.2K |
| A7032 | Cushion for use on nasal mask interface, replacement only, each | 1,200 | $20 | $25.2K |
| A7038 | Filter, disposable, used with positive airway pressure device | 8,280 | $1 | $24.8K |
Showing 1–10 of 44
How this provider's Medicaid billing volume and revenue compare to other Kentucky providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Kentucky median
44 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| E1390 | Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate | 102 | 160 | 5,820 | $40 | $416.1K |
| B4160 | Enteral formula, for pediatrics, nutritionally complete calorically dense (equal to or greater than 0.7 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals,… | 11 | 10 | 830 | $110 | $314.9K |
| E0603 | Breast pump, electric (ac and/or dc), any type | 24 | 30 | 370 | $160 | $149.9K |
| E0601 | Continuous positive airway pressure (CPAP) device | 61 | 160 | 1,680 | $30 | $96.3K |
| 99211 | An established patient presents for an office or other outpatient visit that may not require the presence of a physician or other qualified healthcare professional. | 310 | 540 | 210 | $20 | $78.3K |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 140 | 310 | 330 | $40 | $71.3K |
| 87426 | The lab analyst performs an immunoassay to qualitatively or semiquantitatively evaluate the patient blood specimen for antigens of severe acute respiratory syndrome coronavirus such as SARS–CoV–2,… | 141 | 400 | 360 | $20 | $59.3K |
| A7031 | Face mask interface, replacement for full face mask, each | 21 | 120 | 1,110 | $20 | $55.9K |
| E0470 | Respiratory assist device, bi-level pressure capability, without backup rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive… | 32 | 70 | 440 | $70 | $53.9K |
| E0570 | Nebulizer, with compressor | 35 | 170 | 610 | $30 | $50.8K |
Showing 1–10 of 44
Other providers in the same ZIP code as Ely Drugs Inc, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| T J Samson Community Hospital | KY | General Acute Care Hospital | $0 | $95.7M |
| Golden Gate Bridges | KY | Community/Behavioral Health Agency | $0 | $17.6M |
| T J Samson Community Hospital | KY | Family Medicine Physician | $0 | $15.5M |
| Oaks Behavioral Health PLLC | KY | Psychiatric/Mental Health Nurse Practitioner | $0 | $14.9M |
| Alliance Counseling Associates | KY | Mental Health Counselor | $0 | $12M |
| Ambulance Service Corporation Inc | KY | Ambulance | $1.2M | $3.4M |
| Adult Day Health, Inc. | KY | Adult Day Care Clinic/Center | $0 | $3.4M |
| Martha Seeley, LLC | KY | Family Medicine Physician | $0 | $2.9M |
| Mcpeak Surgery Center LLC | KY | Ambulatory Surgical Clinic/Center | $632.4K | $1.6M |
| Martha Seeley | KY | Family Medicine Physician | $24.7K | $777.3K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.